Protagonist Therapeutics (PTGX) Exchange Rate Effect (2015 - 2022)
Protagonist Therapeutics (PTGX) reported Exchange Rate Effect of $75000.0 for Q4 2022, up 240.91% on a YoY basis from $22000.0 in Q4 2021, and up 142.86% sequentially from -$175000.0 in Q3 2022.
Protagonist Therapeutics (PTGX) Exchange Rate Effect (2015 - 2022) Analysis & Trends
Protagonist Therapeutics (PTGX) has 8 years of Exchange Rate Effect data on file, last reported at $75000.0 in Q4 2022.
- For the quarter ending Q4 2022, Exchange Rate Effect rose 240.91% year-over-year to $75000.0; the trailing twelve-month figure through Dec 2022 stood at -$90000.0 (up 28.57% YoY), and the FY2022 full-year result was -$90000.0, up 28.57% from the prior year.
- Exchange Rate Effect improved to $75000.0 in Q4 2022, from -$175000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $123000.0 in Q3 2020 to a low of -$175000.0 in Q3 2022.
- A 5-year average of -$14666.7 and a median of -$14000.0 in 2019 frame the typical range for Exchange Rate Effect.
- Peak annual rise in Exchange Rate Effect reached 1244.44% in 2020, while the deepest fall reached 1000.0% in 2020.
- Tracing PTGX's Exchange Rate Effect over 5 years: stood at -$87000.0 in 2018, then slumped by 43.68% to -$125000.0 in 2019, then jumped by 116.8% to $21000.0 in 2020, then climbed by 4.76% to $22000.0 in 2021, then soared by 240.91% to $75000.0 in 2022.
- Business Quant data shows PTGX's Exchange Rate Effect at $75000.0 in Q4 2022, -$175000.0 in Q3 2022, and -$19000.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Protagonist Therapeutics | 8.81 Bn | 8.81 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 75,000.00 |
| Dec 31, 2022 | 75,000.00 |
| Sep 30, 2022 | -175,000.00 |
| Sep 30, 2022 | -175,000.00 |
| Jun 30, 2022 | -19,000.00 |
| Jun 30, 2022 | -19,000.00 |
| Mar 31, 2022 | 29,000.00 |
| Mar 31, 2022 | 29,000.00 |
| Dec 31, 2021 | 22,000.00 |
| Dec 31, 2021 | 22,000.00 |
| Sep 30, 2021 | -74,000.00 |
| Sep 30, 2021 | -74,000.00 |
| Jun 30, 2021 | -51,000.00 |
| Jun 30, 2021 | -51,000.00 |
| Mar 31, 2021 | -23,000.00 |
| Mar 31, 2021 | -23,000.00 |
| Dec 31, 2020 | 21,000.00 |
| Dec 31, 2020 | 21,000.00 |
| Sep 30, 2020 | 123,000.00 |
| Sep 30, 2020 | 123,000.00 |